$APGE
Apogee Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is APGE up today? It is at $134.95 (+0.07%). See the catalyst behind the move, real-time alerts the moment APGE spikes, and full due diligence on APGE — key stats, earnings, dilution and insider activity. Free.
Get free $APGE alerts the moment volume spikes
Be first to know when $APGE makes an unusual move. Create a free account to track $APGE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $134.95
- Change today
- +0.07%
- Previous close
- $134.85
- 52-week range
- $35.39 – $134.99
- Market cap
- $10.21B
- Shares outstanding
- 75.7M Live vendor count
- Institutional own.
- 99.9%
- Total held
- 99.9%
- Tradeable float
- 76K 0% of shares · after 100% institutions
- Short interest
- 4.3M ▲ +1% vs prior · as of 2026-08-14
- Days to cover
- 3.2d
- Avg daily volume
- 1.3M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 0.5x
- 15m
- 0.7x
- 1h
- 0.8x
- 1D
- 0.5x
Get free APGE + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $APGE moving today?
Here is the latest on APGE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for APGE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMerger / acquisition agreementPrice $0.00001/share, from an SEC filing. Read it →Latest filing4Ownership documentAug 11, 2026 · 15 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
Insiders selling0 buys, 10 sells last 3 months (0/41 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Fairmount Funds Management Llc Director | Other | 42K 0.06% of company | added 11% | 443K | $718K at $17.00 | Aug 7, 26 |
Dambkowski Carl Officer | Sold (automatic/other) | -6K | sold 3.2% | 168K | $738K at $134.17 | Aug 5, 26 |
Dambkowski Carl Officer | Other | 4K | added 2.4% | 174K | $94K at $22.86 | Aug 5, 26 |
Henderson Jane Officer | Sold (automatic/other) | -15K 0.02% of company | sold 8.7% | 158K | n/a | Jul 24, 26 |
Dambkowski Carl Officer | Sold (automatic/other) | -8K 0.01% of company | sold 4.5% | 170K | n/a | Jul 14, 26 |
Henderson Michael Thomas Officer | Sold (automatic/other) | -75K 0.10% of company | sold 7.5% | 921K | n/a | Jul 10, 26 |
Henderson Michael Thomas Officer | Sold (automatic/other) | -20K 0.03% of company | sold 2.0% | 996K | $2.7M at $133.63 | Jul 8, 26 |
Dambkowski Carl Officer | Sold (automatic/other) | -6K | sold 3.0% | 178K | $730K at $132.74 | Jul 1, 26 |
Dambkowski Carl Officer | Other | 4K | added 2.3% | 183K | $94K at $22.86 | Jul 1, 26 |
Henderson Michael Thomas Officer | Sold (automatic/other) | -80K 0.1% of company | sold 7.3% | 1.02M | $10.6M at $132.54 | Jun 22, 26 |
Dambkowski Carl Officer | Sold (automatic/other) | -26K 0.03% of company | sold 13% | 179K | $3.5M at $132.60 | Jun 22, 26 |
Henderson Michael Thomas Officer | Sold (automatic/other) | -20K 0.03% of company | sold 1.8% | 1.10M | $1.6M at $82.21 | Jun 10, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $APGE runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 5,000,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $328.2M in size · Priced at $70/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$APGE Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$APGE Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to APGE
Comparable names in biological products, (no diagnostic substances), closest in size first.
APGE stock FAQ
Why is $APGE moving today?
Here is the latest on APGE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for APGE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the APGE stock price today?
APGE last traded at $134.95, up 0.07% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live APGE alerts?
The APGE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged APGE 0 times in the last 30 days.
What exchange is APGE on?
APGE (Apogee Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $10.21B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is APGE good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge APGE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.